Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s):  FENC

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.


TSX:FRX - Post by User

Comment by SharkRod812on Mar 11, 2004 8:42am
159 Views
Post# 7192455

RE: Oversold and gapping

RE: Oversold and gappingI was being facetious. I've seen this sort of trading activity on a number of different stocks that I have owned. They all ended up going on major runs from the levels at which they were capped (ie. doubles and triples.) One can only speculate as to what the motives/strategies are for capping a stock--we all know the markets are fair and free of manipulation. Also, the reverse split doesn't worry me in the slightest. It is the right thing for AHX IMO. If the company was in dire financial straits or about to lose its listing, that would be another story. The timing of upcoming events (RS, trial news, ASCO, etc.) and the investments being made by the big fish, suggests to me that AHX is building one big launch pad. Like I said, enjoy the cheap shares while they're available. I bought a couple thousand more yesterday. Good luck.
Bullboard Posts